Background {#Sec1}
==========

Lung cancer is a cancer with less than 15% survival rate and is a leading cause of patients' death worldwid e\[[@CR1]--[@CR4]\]. It is a complex process requiring the acquisition of genetic mutations which confer the malignant phenotype as well as epigenetic alteration s\[[@CR5]\]. Unfortunately, the number of lung cancer related deaths is rapidly increasing each year, and the early diagnosis is crucial to increase the curability chance of patients.

Some genes were found to be associated with the risk of lung cance r\[[@CR6]--[@CR8]\]. The vascular endothelial growth factor (VEGF), is one of the key growth factors, that regulates vascular development and angiogenesis and plays an important role in the growth and progression of human cancers, including lung carcinom a \[[@CR9], [@CR10]\]. The current evidence indicated that VEGF gene polymorphism is associated with the susceptibility of some cancer s\[[@CR11]\]. There is lack of good diagnostic methods that predict the risk of lung cancer, and which etiology is complicated and not clear.

Several reports were published on the relationship between VEGF -2578C \> A gene polymorphism and lung cancer susceptibility. We conducted this meta-analysis to evaluate the association between VEGF -2578C \> A gene polymorphism and the risk of lung cancer.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

The relevant literature was searched and included using the electronic databases of CBM-disc (China Biological Medicine Database) and PubMed on September the 1st, 2018. The retrieval strategy of "(vascular endothelial growth factor OR VEGF) AND (lung cancer OR lung carcinoma) AND (polymorphism OR polymorphisms)" was entered into the databases. The additional literature was obtained from cited references in recruited studies.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

### Inclusion criteria {#Sec5}

\(1\) Patients outcomes must be lung carcinoma; (2) There should be two comparison groups (lung cancer group vs control group); (3) The studies should show data for VEGF -2578C \> A genotype distribution.

### Exclusion criteria {#Sec6}

\(1\) Editorials and review articles; (2) Case reports; (3) Preliminary outcome not on VEGF -2578C \> A gene polymorphism or lung cancer; (4) Studying the role VEGF gene expression in cancers; (5) Multiple publications.

Data extraction and synthesis {#Sec7}
-----------------------------

The data was searched and extracted by two investigators that were independent from each eligible study. The investigators analyzed the data based on the first author's surname, location of the performed study, year of publication, the number of cases and controls for VEGF -2578C \> A genotypes and the control source of the control group. Disagreements were resolved by discussion.

Statistical analysis {#Sec8}
--------------------

Revman 5 (Cochrane Library, UK) was applied to calculate the data extracted from each literature. When the *P* value for the heterogeneity test was less than 0.1, a random effects model was applied. Otherwise, the pooled statistic was counted using the fixed effects model. Odds ratios (OR) were used to express the dichotomous data, and 95% confidence intervals (CI) were also counted. A P value of less than 0.05 was regarded as the pooled OR, to be notably significant. *I*^*2*^ was applied to detect the heterogeneity among the included investigations. According to the source of the controls, sensitivity analysis was also performed (population-based vs hospital-based). Stata 11.0 was used to test the publication bias. The Begg tes t\[[@CR12]\] and the Egger tes t\[[@CR13]\] were applied to assess the publication bias (*P* \< 0.1 was considered significant), when the sample size of included studies was more than ten.

Results {#Sec9}
=======

Study characteristics {#Sec10}
---------------------

A total of 14 studie s\[[@CR14]--[@CR27]\] on the association between VEGF -2578C \> A gene polymorphism and the susceptibility of lung cancer, were included into this meta-analysis (Table [1](#Tab1){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}). The data of our interest were extracted (Table [1](#Tab1){ref-type="table"}). Those 14 investigations contained 3120 patients with lung cancer and 3540 controls. The method for the detection of VEGF -2578C \> A gene polymorphism in all the included studies, involved the use of restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR). We have calculated the allele frequencies of the variant allele (A allele) and found that the frequency of A allele in the lung cancer group was 27.7%, and it in control group was 24.2%. Table 1General characteristics of the included studies in this meta-analysis for VEGF -2578C \> A gene polymorphism with lung cancer riskFirst author,CountryEthnicityControlDetectingCaseControlyear/DistrictsourcemethodsAACACCTotalAACACCTotalWang 2008ChinaAsianPopulation-baseRFLP-PCR2312722737722107287416Liang 2009ChinaAsianPopulation-baseRFLP-PCR1428129171456112172Wang 2009ChinaAsianPopulation-baseRFLP-PCR211041753001675209300Liu 2010ChinaAsianPopulation-baseRFLP-PCR137485172765112184Li 2010ChinaAsianPopulation-baseRFLP-PCR122511315034998150Yuan 2011ChinaAsianPopulation-baseRFLP-PCR18108125251893154255Li 2012ChinaAsianPopulation-baseRFLP-PCR1235108155333114150de Mello 2013PortugalCaucasianPopulation-baseRFLP-PCR267543144277344144Geng 2013ChinaAsianPopulation-baseRFLP-PCR16118126260989162260Wang 2014ChinaAsianPopulation-baseRFLP-PCR211041753001675209300Deng 2014ChinaAsianPopulation-baseRFLP-PCR633266574162110Liu 2015ChinaAsianPopulation-baseRFLP-PCR2016423041423138177338Krupnova 2015BelarusCaucasianHospital-basedRFLP-PCR3190411629118683360Naykoo 2017IndiaAsianPopulation-baseRFLP-PCR51702419955145201401*RFLP-PCR* Restriction fragment length polymorphism polymerase chain reaction, *VEGF* Vascular endothelial growth factor Fig. 1Flow chart of the study search and selection

Relationship between VEGF -2578C \> a gene polymorphism and lung cancer susceptibility in overall populations {#Sec11}
-------------------------------------------------------------------------------------------------------------

VEGF -2578C \> A A allele and CC genotype were associated with lung cancer risk; however, the AA genotype was not found in overall populations (A allele: OR = 1.26, 95% CI: 1.08--1.46, *P* = 0.003, Fig. [2](#Fig2){ref-type="fig"}; AA genotype: OR = 1.29, 95% CI: 0.89--1.89, *P* = 0.18, Fig. [3](#Fig3){ref-type="fig"}; CC genotype: OR = 0.72, 95% CI: 0.54--0.95, *P* = 0.02, Fig. [4](#Fig4){ref-type="fig"}; Table [2](#Tab2){ref-type="table"}). Fig. 2Association between VEGF -2578C \> A A allele and lung cancer susceptibility in overall populations Fig. 3Association between VEGF -2578C \> A AA genotype and lung cancer susceptibility in overall populations Fig. 4Association between VEGF -2578C \> A CC genotype and lung cancer susceptibility in overall populations Table 2Meta-analysis of the association of VEGF -2578C \> A gene polymorphism with lung cancer riskGenetic contrastsGroup and subgroupsStudies numberQ test\
P-valueModel selectedOR (95%CI)PA vs COverall14\<0.0001Random1.26 (1.08,1.46)0.003Asian120.001Random1.33 (1.15,1.55)0.0002Caucasian20.43Fixed0.90 (0.74,1.11)0.33AA vs CA + CCOverall14\<0.0001Random1.29 (0.89,1.89)0.18Asian120.0001Random1.45 (0.92,2.28)0.11Caucasian20.42Fixed0.78 (0.55,1.12)0.18CC vs CA + AAOverall14\<0.00001Random0.72 (0.54,0.95)0.02Asian12\<0.00001Random0.68 (0.50,0.93)0.01Caucasian20.64Fixed1.06 (0.76,1.47)0.74Sensitivity analysis according to source of the controls from population-based A vs COverall130.0008Random1.30 (1.05,1.72)0.0003 AA vs CA + CCOverall130.0002Random1.39 (0.92,2.08)0.12 CC vs CA + AAOverall13\<0.00001Random0.70 (0.52,0.93)0.02Sensitivity analysis according to source of the controls from hospital-based T vs COverall1--Fixed0.85 (0.65,1.10)0.21 TT vs CT + CCOverall1--Fixed0.70 (0.44,1.11)0.13 CC vs CT + TTOverall1--Fixed1.13 (0.74,1.74)0.58

Relationship between VEGF -2578C \> a gene polymorphism and lung cancer susceptibility in Asians {#Sec12}
------------------------------------------------------------------------------------------------

In this meta-analysis, VEGF -2578C \> A A allele, and CC genotype were associated with the risk of lung cancer in Asians; however, the AA genotype was not (A allele: OR = 1.33, 95% CI: 1.15--1.55, *P* = 0.0002; AA genotype: OR = 1.45, 95% CI: 0.92--2.28, *P* = 0.11; CC genotype: OR = 0.68, 95% CI: 0.50--0.93, *P* = 0.01; Table [2](#Tab2){ref-type="table"}).

Relationship between VEGF -2578C \> a gene polymorphism and lung cancer susceptibility in Caucasians {#Sec13}
----------------------------------------------------------------------------------------------------

In this meta-analysis, VEGF -2578C \> A gene polymorphism was not associated with the susceptibility of lung cancer in Caucasians (A allele: OR = 0.90, 95% CI: 0.74--1.11, *P* = 0.33; AA genotype: OR = 0.78, 95% CI: 0.55--1.12, *P* = 0.18; CC genotype: OR = 1.06, 95% CI: 0.76--1.47, *P* = 0.74; Table [2](#Tab2){ref-type="table"}).

Sensitivity analysis {#Sec14}
--------------------

The sensitivity analysis for the association between VEGF -2578C \> A gene polymorphism and lung cancer susceptibility was also performed by the source of the controls (population-based vs hospital-based). In the sensitivity analysis using population-based, the VEGF -2578C \> A A allele and CC genotype were associated with lung cancer risk; however, the AA genotype was not (Table [2](#Tab2){ref-type="table"}). In the sensitivity analysis using the hospital-based control, VEGF -2578C \> A gene polymorphism was not associated with lung cancer susceptibility (Table [2](#Tab2){ref-type="table"}).

Evaluation of publication bias {#Sec15}
------------------------------

No publication bias was found for the overall populations (Begg *P* = 0.807, funnel plot was presented in Fig. [5](#Fig5){ref-type="fig"}; Egger *P* = 0.505), and Asians (Begg *P* = 0.938, Egger *P* = 0.827). Fig. 5Funnel plot to assess publication bias for the association of VEGF -2578C \> A gene polymorphism with lung cancer susceptibility in overall populations

Discussion {#Sec16}
==========

VEGF is regarded as an important factor taking part in the inactivation of pro-carcinogens, which contribute to cancer. In this study, we included 14 studies into our meta-analysis. We investigated whether the VEGF -2578C \> A gene polymorphism is a valuable indicator for lung cancer susceptibility, and attempted to draw robust results. In our meta-analysis, we found that there was a marked association between VEGF -2578C \> A A allele / CC genotype and lung cancer risk in overall and Asian populations. However, VEGF -2578C \> A gene polymorphism was not associated with the risk of lung cancer in Caucasians. The sample size of the included studies was larger than that of other meta-analyses, and the results on the association between VEGF -2578C \> A gene polymorphism and lung cancer risk might be more robust. The pooled OR for A allele was 1.26 for overall populations and 1.33 for Asians; while, for the CC genotype the odds ratio was less than 1. It indicated that high CC genotype was a protective genotype (good genotype); however, A allele was a negative gene allele. The AA genotype was not associated with lung cancer risk, which might due to the small sample size of included studies, and therefore, more studies should be conducted to confirm this result. Nevertheless, the results for the Caucasian population were less robust, also due to the small number of included studies. Additional studies should be performed to confirm this result.

In the sensitivity analysis by the controls source, we found that, in the sensitivity analysis using the population-based control, the VEGF -2578C \> A A allele / CC genotype was associated with lung cancer susceptibility. However, in the sensitivity analysis using the hospital-based control, VEGF -2578C \> A gene polymorphism was not associated with lung cancer susceptibility.

Publication bias was also analyzed, and we found that there was no publication bias for overall and Asians populations. This suggests that the conclusion from our meta-analysis was robust. However, additional well-designed studies should be performed to confirm this result in the future.

In a previous study, Deng et al .\[[@CR15]\] recruited four reports into their study using a meta-analysis method, and showed that the CC genotype was associated with lung cancer; however, A allele and AA genotype were not. Chen et al .\[[@CR28]\] also included four studies into their meta-analysis, and obtained a similar result. Lin et al .\[[@CR29]\] included seven studies into their meta-analysis, and reported that the A allele was associated with lung cancer, but the AA and CC genotypes were not. Our meta-analysis indicated that there was an association between A allele, CC genotype and lung cancer risk in overall and Asian populations. The sample size in our meta-analysis was larger than the previous meta-analyses, and the outcome in our meta-analysis might be more robust. In this study, we found that the CC genotype is the dominant genotype associated with lung cancer risk. We speculated that the CC genotype might be associated with high levels of VEGF, and that the increased VEGF was associated with lung cancer risk.

In the test of publication bias, two points were located on or out of scope, indicating publication bias. We deleted the two studies and conducted a further meta-analysis, and found the results were similar.

Conclusions {#Sec17}
===========

The results in our study support that VEGF -2578C \> A A allele / CC genotype was associated with lung cancer susceptibility in overall and Asian populations. However, additional well-designed investigations of this association are required to confirm these results.

VEGF

:   Vascular endothelial growth factor
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